CN1050045C - Traditional Chinese medicine-Liu's Hua'ai huixiangdan for treating carcinoma of esophagus - Google Patents
Traditional Chinese medicine-Liu's Hua'ai huixiangdan for treating carcinoma of esophagus Download PDFInfo
- Publication number
- CN1050045C CN1050045C CN93104343A CN93104343A CN1050045C CN 1050045 C CN1050045 C CN 1050045C CN 93104343 A CN93104343 A CN 93104343A CN 93104343 A CN93104343 A CN 93104343A CN 1050045 C CN1050045 C CN 1050045C
- Authority
- CN
- China
- Prior art keywords
- radix
- patent medicine
- chinese patent
- medicine
- mylabris
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 208000017897 Carcinoma of esophagus Diseases 0.000 title claims description 11
- 206010030155 Oesophageal carcinoma Diseases 0.000 title claims description 11
- 201000005619 esophageal carcinoma Diseases 0.000 title claims description 11
- 239000003814 drug Substances 0.000 claims abstract description 26
- 241000239226 Scorpiones Species 0.000 claims abstract description 11
- 241000208340 Araliaceae Species 0.000 claims abstract description 8
- 244000153234 Hibiscus abelmoschus Species 0.000 claims abstract description 8
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 8
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 8
- 235000008434 ginseng Nutrition 0.000 claims abstract description 8
- 239000003998 snake venom Substances 0.000 claims abstract description 7
- 241000124079 Mylabris Species 0.000 claims description 10
- 241000131808 Scolopendra Species 0.000 claims description 10
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 claims description 10
- 241000237903 Hirudo Species 0.000 claims description 9
- 241001312741 Gekko swinhonis Species 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 4
- 238000003809 water extraction Methods 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 3
- 238000007670 refining Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 8
- 206010028980 Neoplasm Diseases 0.000 abstract description 5
- 235000013305 food Nutrition 0.000 abstract description 4
- 201000011510 cancer Diseases 0.000 abstract description 3
- 230000036737 immune function Effects 0.000 abstract description 3
- 238000005728 strengthening Methods 0.000 abstract description 3
- 208000024891 symptom Diseases 0.000 abstract description 3
- 230000001225 therapeutic effect Effects 0.000 abstract description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 2
- 208000026435 phlegm Diseases 0.000 abstract description 2
- 239000003053 toxin Substances 0.000 abstract 3
- 231100000765 toxin Toxicity 0.000 abstract 3
- 208000000461 Esophageal Neoplasms Diseases 0.000 abstract 2
- 201000004101 esophageal cancer Diseases 0.000 abstract 2
- 206010004542 Bezoar Diseases 0.000 abstract 1
- 241000258920 Chilopoda Species 0.000 abstract 1
- 208000035240 Disease Resistance Diseases 0.000 abstract 1
- 241000545744 Hirudinea Species 0.000 abstract 1
- 241000623906 Lytta vesicatoria Species 0.000 abstract 1
- 241001038563 Pseudostellaria Species 0.000 abstract 1
- 210000003056 antler Anatomy 0.000 abstract 1
- 231100000614 poison Toxicity 0.000 description 7
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 229940079593 drug Drugs 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 230000007096 poisonous effect Effects 0.000 description 4
- 206010052428 Wound Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 235000008216 herbs Nutrition 0.000 description 2
- 238000003672 processing method Methods 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 1
- 238000003723 Smelting Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The present invention relates to a Chinese patent medicine for treating esophagus cancer. The remission rate in the existing Chinese patent medicine for treating esophagus cancer is only from 10 to 40%. The Chinese patent medicine of the present invention adopts the therapeutic principles of attacking toxin with toxin, clearing heat for removing toxin, dissipating phlegm, resolving masses and strengthening body resistance. The Chinese patent medicine of the present invention is prepared from 14 kinds of traditional Chinese medicine of aresenolite, blister beetle, secretio bufonis, snake venom, centipede, dried leech, scorpion tail, gecko, moschus, cow-bezoar, radix adenophorae, ginseng, pseudostellaria root, deglued antler, etc. to be prepared into the patent medicine. After patients take the medicine, cancer cells can be efficiently killed, the immunological function of the human body is enhanced, the symptom that the middle-phase patient and the late-phase patient can not eat foods is improved, the disease resistance of the human body is raised, and the clinical efficiency reaches 67.59%. Simultaneously, when taken by patients, the patent medicine has the advantages of no obvious side effect, high safety and reliability.
Description
The invention belongs to a kind of Chinese patent medicine for the treatment of the esophageal carcinoma.
The esophageal carcinoma is one of common cancer, and mortality rate is higher, and serious harm human life health except that symptomatic treatment, is gone back inefficacy Chinese patent medicine preferably at present.The nearly curative effect of traditional Chinese medicine on esophageal carcinoma during the last ten years obtains certain progress, but show according to the documents and materials statistics, remission rate with the treatment by Chinese herbs esophageal carcinoma only can reach 10-40% (seeing " Chinese and Western is in conjunction with the oncology " 1989.12 P400-425 pages or leaves) merely, as seen curative effect can not be satisfactory, generally also have simultaneously a problem in esophageal carcinoma therapy: the middle and advanced stage patient is owing to can not take food, cause physical weakness, also influenced therapeutic effect greatly.
The present invention aims to provide the very fast reduction of patient disease of a kind of energy, improve himself resistance against diseases and obtain the pure Chinese medicinal preparation of the treatment esophageal carcinoma of higher curative effect.
The object of the present invention is achieved like this: dosage and the formulation ratio of 100 days each courses of treatment of this Chinese patent medicine are:
Arsenicum sablimatum 9-12g Venenum Bufonis 28-31g snake venom 13-16g
49 Hirudo 85-93g of Mylabris 28-31g Scolopendra
Scorpion tail 12-17g Gekko Swinhonis 200-250g Moschus 1-3g
Calculus Bovis 1g sand oozes 100-130g Radix Ginseng 200-250g
Radix Pseudostellariae 200-250g Cornu Cervi Degelatinatum 25-32g
Arsenicum sablimatum wherein, Scolopendra, Hirudo, scorpion tail, Radix Adenophorae (Radix Glehniae) be all earlier through with the processing of water extraction, and Mylabris is earlier through traditional liter refining processing, again with above-mentioned various compositions traditional method decocting, concentrated make Powdered.
We have adopted the prescription therapeutic principle of " treating the poisonous disease with poisonous drugs ", " heat-clearing and toxic substances removing ", " dissipating phlegm and resolving masses ", " the body resistance strengthening and constitution consolidating "; but as the Mylabris in the side, Venenum Bufonis, scorpion tail, Scolopendra, Gekko Swinhonis, arsenicum sablimatum treating the poisonous disease with poisonous drugs, kill and wound cancerous cell; Calculus Bovis, Moschus heat-clearing and toxic substances removing, blood circulation promoting and blood stasis dispelling; Radix Ginseng, Radix Pseudostellariae, Cornu Cervi Degelatinatum strengthening vital QI to eliminate pathogenic factors increase immunologic function.
The part Chinese materia medica tocixity of selecting for use among the we is bigger, in order to reduce its toxicity, and guarantees that fully it kills and wounds the effect of cancerous cell, and this class medicine all through rising processing such as refining or water extraction concentrate, greatly reduces its toxicity, has guaranteed the safety to human body.This medicine is through acute poison test, give 10 white mice dosing times by people's dose 104 multiple doses, observe and do not have death in 6 days, through routine clinical trial surplus in the of 4500 more than 3 years, find no obvious toxic-side effects, and 60% middle and advanced stage patient medication can improve symptom in 7-15 days, became smooth feed by not taking food.
" tumor efficiency common index " with reference to the whole nation " Chinese and Western is in conjunction with the tumor academic conference " in December, 1979 formulation is foundation, 108 routine patient with esophageal carcinoma have been made the clinical efficacy statistical procedures, clinical symptoms is alleviation person's 50 examples fully, part alleviation person 23 examples, and total effective rate is 67.59%
Through 54 of this group patients are followed up a case by regular visits to, above patient's 11 examples of a year and a half of surviving, existence patient's 15 examples more than a year, existence patient's 21 examples more than 6 months, existence patient's 7 examples more than 3 months, mean survival time (MST), prolong 9.6 months, and this medicine also has better curative effect to other digestive tract cancer.
This Chinese medicine can effectively kill and wound cancerous cell, strengthen patient's immunologic function simultaneously, improve the situation that the middle and advanced stage patient can not take food, improve the resistance against diseases of human body, thereby make clinical effective rate reach 67.59%, considerably beyond the average effectiveness level of present other treatment by Chinese herbs esophageal carcinoma, this medicine can also on average prolong survival time of patients more than 9 months, and take this medicine and do not have obvious toxic-side effects, safe and reliable.
The invention will be further described below in conjunction with embodiment.
Embodiment 1: by dosage 100 days per courses of treatment, its proportioning prescription is:
Arsenicum sablimatum 10g Venenum Bufonis 30g snake venom 15g
9 Hirudo 90g of Mylabris 30g Scolopendra
Scorpion tail 15g Gekko Swinhonis 240g Moschus 2g
Calculus Bovis 1g Radix Adenophorae (Radix Glehniae) 120g Radix Ginseng 240g
Radix Pseudostellariae 240g Cornu Cervi Degelatinatum 30g
With arsenicum sablimatum, Scolopendra, Hirudo, scorpion tail, Radix Adenophorae (Radix Glehniae) water extraction wherein, Mylabris is processed with traditional smelting method that rises, again with mentioned component medicine water boiling concentration, refinement, finally making the about 420g of powdered drug packs in 1200 capsules, every about 0.35 gram, every day three times when taking, each four, 100 days courses of treatment.
Embodiment 2: by dosage 100 days per courses of treatment, its formulation ratio is:
Arsenicum sablimatum 9g Venenum Bufonis 28g snake venom 13g
49 Hirudo 85g of Mylabris 28g Scolopendra
Scorpion tail 12g Gekko Swinhonis 200g Moschus 1g
Calculus Bovis 1g Radix Adenophorae (Radix Glehniae) 100g Radix Ginseng 200g
Radix Pseudostellariae 200g Cornu Cervi Degelatinatum 25g
Processing method is the same.
Embodiment 3: by dosage 100 days per courses of treatment, its formulation ratio is:
Arsenicum sablimatum 12g Venenum Bufonis 31g snake venom 16g
49 Hirudo 93g of Mylabris 31g Scolopendra
Scorpion tail 17g Gekko Swinhonis 250g Moschus 3g
Calculus Bovis 1g Radix Adenophorae (Radix Glehniae) 130g Radix Ginseng 250g
Radix Pseudostellariae 240g Cornu Cervi Degelatinatum 32g
Processing method is the same.
Claims (2)
1, a kind of Chinese patent medicine for the treatment of the esophageal carcinoma, it is characterized in that: it is made by following materials of weight proportions:
Arsenicum sablimatum 9-12g Venenum Bufonis 28-31g snake venom 13-16g
49 Hirudo 85-93g of Mylabris 28-31g Scolopendra
Scorpion tail 12-17g Gekko Swinhonis 200-250g Moschus 1-3g
Calculus Bovis 1g Radix Adenophorae (Radix Glehniae) 100-130g Radix Ginseng 200-250g
Radix Pseudostellariae 200-250g Cornu Cervi Degelatinatum 25-32g
Arsenicum sablimatum wherein, Scolopendra, Hirudo, scorpion tail, Radix Adenophorae (Radix Glehniae) be all earlier through with the processing of water extraction, and Mylabris is earlier through traditional liter refining processing, again with the various compositions of above-mentioned prescription traditional method decocting, concentrated make Powdered.
2, Chinese patent medicine according to claim 1 is characterized in that: it is made by following materials of weight proportions material:
Arsenicum sablimatum 10g Venenum Bufonis 30g snake venom 15g
49 Hirudo 90g of Mylabris 30g Scolopendra
Scorpion tail 15g Gekko Swinhonis 240g Moschus 2g
Calculus Bovis 1g Radix Adenophorae (Radix Glehniae) 120g Radix Ginseng 240g
Radix Pseudostellariae 240g Cornu Cervi Degelatinatum 30g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN93104343A CN1050045C (en) | 1993-04-17 | 1993-04-17 | Traditional Chinese medicine-Liu's Hua'ai huixiangdan for treating carcinoma of esophagus |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN93104343A CN1050045C (en) | 1993-04-17 | 1993-04-17 | Traditional Chinese medicine-Liu's Hua'ai huixiangdan for treating carcinoma of esophagus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1094620A CN1094620A (en) | 1994-11-09 |
| CN1050045C true CN1050045C (en) | 2000-03-08 |
Family
ID=4985145
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN93104343A Expired - Fee Related CN1050045C (en) | 1993-04-17 | 1993-04-17 | Traditional Chinese medicine-Liu's Hua'ai huixiangdan for treating carcinoma of esophagus |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1050045C (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1114422C (en) * | 2000-03-13 | 2003-07-16 | 徐忠廷 | Anti-cancer Chinese-medicinal pill |
| CN101347459B (en) * | 2008-09-10 | 2013-01-02 | 刘皇琼 | Medicine for treating cancer |
| CN102406841B (en) * | 2011-12-02 | 2014-03-05 | 龚定军 | Traditional Chinese medicine for treating tumors |
| CN102416083B (en) * | 2011-12-12 | 2012-07-18 | 许从玉 | Medicinal composition for treating esophagus cancer |
-
1993
- 1993-04-17 CN CN93104343A patent/CN1050045C/en not_active Expired - Fee Related
Non-Patent Citations (3)
| Title |
|---|
| 《中西医结合杂志》1989，9(8) 1989.8.30 强致和，复方斑蝥丸加减治疗中晚期食管癌、贲门癌126例 * |
| 《北京中医》1986，(3) 1986.3.30 宋洪恩，复方壁酒治疗食管癌42例疗效观察 * |
| 《北京中医》1986，(3) 1986.3.30 宋洪恩，复方壁酒治疗食管癌42例疗效观察;《中西医结合杂志》1989，9(8) 1989.8.30 强致和，复方斑蝥丸加减治疗中晚期食管癌、贲门癌126例 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1094620A (en) | 1994-11-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1272057C (en) | Chinese traditional medicine for treating facial paralysis, facial spasm and trifacial neuralgia | |
| CN1050045C (en) | Traditional Chinese medicine-Liu's Hua'ai huixiangdan for treating carcinoma of esophagus | |
| CN1895620A (en) | Chinese-medicinal composition for treating coronary heart disease | |
| CN100411666C (en) | Broad-specturm medicine for treating snake venom poisoning | |
| CN1255150C (en) | Chinese medicine preparation for curing hyperosteogeny and its preparation method | |
| CN103239674B (en) | Antineoplastic traditional Chinese medicine composition and preparation method thereof | |
| CN1055014C (en) | Medicine powder for curing hepatitis B | |
| CN1057220C (en) | Compound anticancer Chinese medicine | |
| CN1169304A (en) | Pill made from eight Chinese medicinal herbs and production technology thereof | |
| CN1537559A (en) | Traditional Chinese medicine for treating AIDS | |
| CN100335119C (en) | Chinese medicinal composition for treating enteritis | |
| CN1244335C (en) | Influenze resisting medicine | |
| CN1177592C (en) | Application of Radix Radix Radix Radix Extract Total Saponins in the Preparation of Drugs for Treating Myocarditis | |
| CN1093421C (en) | Process for preparing snuff to treat hepatitis B | |
| CN1245184C (en) | A kind of traditional Chinese medicine preparation for treating insomnia and preparation method thereof | |
| CN100560087C (en) | Pharmaceutical composition for treating malignant tumors and preparation method thereof | |
| CN1292765C (en) | Pharmaceutical composition, its preparation process and usage | |
| CN1239168C (en) | Medicine for treating constipation and preparation method thereof | |
| CN1053108C (en) | Chinese patent medicine for treating primary liver cancer | |
| CN1150941C (en) | Drug for treating rheumatism | |
| CN106344680A (en) | Traditional Chinese medicinal composition with effects of expelling wind and relieving cold-aggravated arthralgia and preparation method thereof | |
| CN1122236A (en) | Medicine for treating AIDS and its preparing method | |
| CN1208630A (en) | Traditional Chinese medicine series used for anticancer and method for preparing same | |
| CN1087620C (en) | Medicinal composition for treating stomach and intestine ulcer | |
| CN1200289A (en) | Sanhua xietingye liquid medicine for treating diarrhea made of three flowers |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |